December 3, 2018 / 12:13 PM / in 14 days

GSK to buy cancer drugmaker Tesaro for $5.1 billion

LONDON, Dec 3 (Reuters) - GlaxoSmithKline said on Monday it had agreed to buy U.S. cancer drug specialist Tesaro for $5.1 billion, marking a major biotech investment by the British drugmaker as its seeks to rebuild its pharmaceuticals portfolio.

Reporting by Ben Hirschler Editing by Edmund Blair

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below